Your SlideShare is downloading. ×
0
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Pathology of the Thyroid Gland
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pathology of the Thyroid Gland

2,794

Published on

0 Comments
5 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,794
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
238
Comments
0
Likes
5
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pathology of the Thyroid Gland Prof. Dipak Shah Department of Pathology UWI, Mona
  • 2. Diseases of the Thyroid Gland <ul><li>Congenital diseases </li></ul><ul><li>Inflammation </li></ul><ul><li>Functional abnormality </li></ul><ul><li>Diffuse and Multinodular goiters </li></ul><ul><li>Neoplasia </li></ul>
  • 3. Inflammation <ul><li>Thyroiditis </li></ul><ul><ul><li>Acute illness with pain </li></ul></ul><ul><ul><ul><li>Infectious </li></ul></ul></ul><ul><ul><ul><ul><li>Acute </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Chronic </li></ul></ul></ul></ul><ul><ul><ul><li>Subacute or granulomatous (De Quervain’s) </li></ul></ul></ul><ul><ul><li>Little inflammation with dysfunction </li></ul></ul><ul><ul><ul><li>Subacute lymphocytic thyroiditis </li></ul></ul></ul><ul><ul><ul><li>Fibrous (Riedel) thyroiditis </li></ul></ul></ul><ul><ul><li>Autoimmune </li></ul></ul><ul><ul><ul><li>Hashimoto thyroiditis </li></ul></ul></ul>
  • 4. HASHIMOTO THYROIDITIS <ul><li>Most common cause of hypothyroidism </li></ul><ul><li>Autoimmune, non-Mendelian inheritance </li></ul><ul><li>45-65 years, F:M = 10-20:1 </li></ul><ul><li>Painless symmetrical enlargement </li></ul><ul><li>Risk of developing </li></ul><ul><ul><li>B-cell non-Hodgkin’s lymphoma </li></ul></ul><ul><ul><li>Other concomitant autoimmune diseases </li></ul></ul><ul><ul><ul><li>Endocrine and non-endocrine </li></ul></ul></ul>
  • 5. Hashimoto Thyroiditis Pathogenesis <ul><li>Immune systems reacts against a variety of thyroid antigens </li></ul><ul><li>Progressive depletion of thyroid epithelial cells which are gradually replaced by mononuclear cells -> fibrosis </li></ul><ul><li>Immune mechanisms may includes: </li></ul><ul><ul><li>CD8+ cytotoxic T cell-mediated cell death </li></ul></ul><ul><ul><li>Cytokine-mediated cell death </li></ul></ul><ul><ul><li>Binding of antithyroid antibodies -> antibody dependent cell-mediated cytotoxicity </li></ul></ul>
  • 6. Hashimoto Thyroiditis <ul><li>Diffuse enlargement </li></ul><ul><li>Firm or rubbery </li></ul><ul><li>Pale, yellow-tan, firm & somewhat nodular cut surface </li></ul>
  • 7. Hashimoto Thyroiditis <ul><li>Massive lymphoplasmcytic infiltration with lymphoid follicles formation </li></ul><ul><li>Destruction of thyroid follicles </li></ul><ul><li>Remaining follicles are small and many are lined by Hurthle cells </li></ul><ul><li>Increased interstitial connective tissue </li></ul>
  • 8. Functional Abnormality <ul><li>Hyperfunction </li></ul><ul><ul><li> in level of hormone -> toxic effects </li></ul></ul><ul><ul><ul><li>Due to: </li></ul></ul></ul><ul><ul><ul><ul><li>Diffuse hyperplasia </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Hyperfunctioning multinodular goiter </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Hyperfunctioning adenoma </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Subacute lymphocytic (painless) thyroiditis </li></ul></ul></ul></ul>
  • 9. Functional Abnormality <ul><li>Hypofunction </li></ul><ul><ul><li> in level of hormone -> impair development in infants and slowing of physical and mental ability in adults </li></ul></ul><ul><ul><ul><li>Due to: </li></ul></ul></ul><ul><ul><ul><ul><li>Postablation </li></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Surgery </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Radiation </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><li>Autoimmune thyroiditis </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Drugs </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Dyshormonogenetic </li></ul></ul></ul></ul>
  • 10. Graves Disease <ul><li>Most common cause of endogenous hyperthyroidism </li></ul><ul><li>Characterized by hyperthyroidism, ophthalmopathy with exophthalmos and dermopathy (pretibial myxedema) </li></ul><ul><li>Autoimmune disease with genetic susceptibility associated with HLA-B8 and DR3 </li></ul><ul><li>Female:Male = 7:1 </li></ul><ul><li>3rd to 4th decades </li></ul><ul><li>Diffuse enlargement with audible bruit </li></ul><ul><li>Wide,staring gaze,lid lag,exophthalmos,pretibial myxedema </li></ul><ul><li>↑ levels of free T 4 & T 3 and ↓ levels of TSH in blood </li></ul><ul><li>↑ uptake of radioactive iodine </li></ul>
  • 11. Graves’ Disease <ul><li>Autoimmune disease with breakdown of helper-T-cell tolerance </li></ul><ul><li>Excessive production of TWO thyroid autoantibodies: </li></ul><ul><li>Thyroid-stimulating antibody (TSAb) & </li></ul><ul><li>Growth-stimulating antibody (GSAb) </li></ul><ul><li>Antibodies bind to the TSH receptor of the follicular cell </li></ul><ul><li>Stimulation of the cell resulting in: </li></ul><ul><li>Increased levels of thyroid hormones & </li></ul><ul><li>Hyperplasia of the thyroid gland </li></ul><ul><li>Hyperthyroidism and Thyroid gland enlargement </li></ul>
  • 12. Graves Disease <ul><li>Symmetrical enlargement of thyroid gland </li></ul><ul><li>Cut-surface is homogenous, soft and appear meaty </li></ul><ul><li>Hyperplasia and hypertrophy of follicular cells </li></ul>
  • 13. Diffuse & Multinodular goiters <ul><ul><li>Reflects impaired synthesis of thyroid hormone most often caused by iodine deficiency </li></ul></ul><ul><ul><li>Impairment leads to compensatory ↑ in TSH levels -> hypertrophy and hyperplasia of follicular cells -> gross enlargement of gland </li></ul></ul><ul><ul><li>Euthyroid metabolic state </li></ul></ul><ul><ul><li>Degree of enlargement is proportional to level and duration </li></ul></ul>
  • 14. Diffuse nontoxic goiter <ul><ul><li>Diffuse non-toxic (simple) goiter </li></ul></ul><ul><ul><ul><li>colloid goiter </li></ul></ul></ul><ul><ul><ul><li>Endemic </li></ul></ul></ul><ul><ul><ul><li>sporadic (dyshormonogenetic) </li></ul></ul></ul>
  • 15. Endemic Goiter <ul><li>Low iodine content in drinking water & food (Himalayas, Alps, Andes, areas far from the sea) </li></ul><ul><li>Prevalence decreasing due to prophylactic iodination of salt </li></ul><ul><li>Iodine deficiency causes decreased hormone levels & consequent elevation in TSH </li></ul>
  • 16. Sporadic Goiter <ul><li>Commonest type of goiter </li></ul><ul><li>Euthyroid, but may be hypo- or hyper- </li></ul><ul><li>Mostly idiopathic, but RARELY, may be caused by: </li></ul><ul><ul><li>Drugs used in Rx of hyperthyroidism </li></ul></ul><ul><ul><li>Goitrogens e.g. cauliflower, cabbage, cassava </li></ul></ul><ul><ul><li>Suboptimal iodine intake </li></ul></ul><ul><ul><li>Hereditary enzymatic defects </li></ul></ul>
  • 17. Multinodular goiter <ul><li>Recurrent episodes of hyperplasia and involution leads to irregular enlargement </li></ul><ul><li>All long standing diffuse endemic and sporadic goiter may eventually convert to multinodular goiter </li></ul><ul><li>Causes most extreme enlargement and may be mistaken for neoplasm </li></ul><ul><li>May arise due to variable response of follicular cells to external stimuli such as trophic hormones </li></ul><ul><li>With uneven follicular hyperplasia, generation of new follicles and uneven accumulation of colloid -> rupture of follicle and vessels ->hemorrhage, scarring & calcification -> nodularity </li></ul>
  • 18. Multinodular Goiter <ul><li>Asymmetric enlargement </li></ul><ul><li>Multinodular </li></ul><ul><li>Haemorrhage </li></ul><ul><li>Calcification </li></ul><ul><li>Fibrosis </li></ul><ul><li>Cystic degeneration </li></ul>
  • 19. Multinodular Goiter <ul><li>Numerous follicles varying in size </li></ul><ul><li>Recent haemorrhage </li></ul><ul><li>Haemosiderin </li></ul><ul><li>Calcification </li></ul><ul><li>Cystic degeneration </li></ul><ul><li>+/- dominant nodule </li></ul>
  • 20. Thyroid Neoplasms <ul><li>I. Primary Tumours </li></ul><ul><ul><ul><li>Epithelial </li></ul></ul></ul><ul><ul><ul><li>Malignant Lymphomas </li></ul></ul></ul><ul><ul><ul><li>Mesenchymal tumours </li></ul></ul></ul><ul><li>II. Metastatic Tumours </li></ul>
  • 21. Epithelial Thyroid Neoplasms <ul><li>Tumours of follicular cells </li></ul><ul><ul><li>Benign (adenomas) </li></ul></ul><ul><ul><ul><li>Follicular adenoma </li></ul></ul></ul><ul><ul><li>Malignant (carcinomas) </li></ul></ul><ul><ul><ul><li>Follicular carcinoma (10-20%) </li></ul></ul></ul><ul><ul><ul><li>Papillary carcinoma (75-85%) </li></ul></ul></ul><ul><ul><ul><li>Undifferentiated (anaplastic) carcinoma (<5%) </li></ul></ul></ul><ul><li>Tumours of C-cells </li></ul><ul><ul><li>Medullary thyroid carcinoma (MTC - 5%) </li></ul></ul>
  • 22. Follicular Adenoma <ul><li>Benign, encapsulated tumor showing evidence of follicular differentiation </li></ul><ul><li>Common </li></ul><ul><li>Predominantly young to middle women </li></ul><ul><li>Presents as solitary thyroid nodule </li></ul><ul><li>Painless nodular mass, cold on isotopic scan </li></ul>
  • 23. Follicular Adenoma <ul><li>Solitary, Variably sized, encapsulated, well-circumscribed with homogenous gray-white to red-brown cut-surface </li></ul><ul><li>+/- degenerative changes </li></ul>
  • 24. Follicular Carcinoma <ul><li>Second most common form, 10-20% </li></ul><ul><li>Females > Males, average age ~ 45 - 55 yr </li></ul><ul><li>Rare in children </li></ul><ul><li>Solitary nodule, painless, cold on isotopic scan </li></ul><ul><li>Widely invasive Vs minimaly invasive </li></ul><ul><li>50% 10 yr survival Vs 90%10 yr survival </li></ul><ul><li>Haematogenous route is preferred mode of spread </li></ul>
  • 25. Follicular Carcinoma <ul><li>Solitary round or oval nodule </li></ul><ul><li>Thick capsule </li></ul><ul><li>Composed of follicles </li></ul><ul><li>Capsular invasion or vascular invasion within our outside capsular wall </li></ul>
  • 26. Papillary Carcinoma <ul><li>Commonest thyroid malignancy, 75-85% </li></ul><ul><li>Female:Male = 2.5:1 </li></ul><ul><li>Mean age at onset = 20 - 40 yr </li></ul><ul><li>May affect children </li></ul><ul><li>Prior head & neck radiation exposure </li></ul><ul><li>Indolent, slow-growing painless mass cold on isotopic scan </li></ul><ul><li>Cervical lymphadenopathy may be presenting feature </li></ul>
  • 27. Papillary Carcinoma <ul><li>Variable size (microscopic to several cm) </li></ul><ul><li>Solid or cystic </li></ul><ul><li>Infiltrative or encapsulated </li></ul><ul><li>Solitary or multicentric (20%) </li></ul>
  • 28. Papillary Carcinoma <ul><li>Papillae or follicles </li></ul><ul><li>Psammoma bodies </li></ul><ul><li>NUCLEAR FEATURES*** </li></ul>
  • 29. Papillary Carcinoma <ul><li>Nuclear Features </li></ul><ul><ul><li>Optically clear (ground glass, Orphan Annie) nuclei </li></ul></ul><ul><ul><li>Nuclear pseudoinclusions or nuclear grooves </li></ul></ul>
  • 30. Papillary Carcinoma Prognosis <ul><li>Excellent but following factors play important role: </li></ul><ul><ul><li>Age and sex </li></ul></ul><ul><ul><li>Size </li></ul></ul><ul><ul><li>Multicentricity </li></ul></ul><ul><ul><li>Extra-thyroid extension </li></ul></ul><ul><ul><li>Distant metastasis </li></ul></ul><ul><ul><li>Total encapsulation, pushing margin of growth & cystic change </li></ul></ul>
  • 31. Anaplastic Carcinoma <ul><li>Rare; < 5% of thyroid carcinomas </li></ul><ul><li>Highly malignant and generally fatal < 1yr. </li></ul><ul><li>Elderly  65 yrs; females slightly > males </li></ul><ul><li>Rapidly enlarging bulky neck mass </li></ul><ul><li>Dysphagia, dyspnoea, hoarseness </li></ul>
  • 32. Anaplastic Carcinoma <ul><li>Large, firm, necrotic mass </li></ul><ul><li>Frequently replaces entire thyroid gland </li></ul><ul><li>Extends into adjacent soft tissue, trachea and oesophagus </li></ul><ul><li>Highly anaplastic cell on histology with: </li></ul><ul><ul><li>Giant, spindle,small or mix cell population </li></ul></ul><ul><li>Foci of papillary or follicular differentiation </li></ul>
  • 33. Anaplastic Carcinoma <ul><li>Cellular pleomorphism </li></ul><ul><li>+/- multinucleated giant cells </li></ul><ul><li>High mitotic activity </li></ul><ul><li>Necrosis </li></ul>
  • 34. Medullary Thyroid Carcinoma (MTC) <ul><li>Malignant tumour of thyroid C cells producing cacitonin </li></ul><ul><li>5 % of all thyroid malignancies </li></ul><ul><li>Sporadic (80%) </li></ul><ul><li>Rest in the setting of MEN IIA or B or as familial without associated MEN syndrome </li></ul>
  • 35. Medullary Thyroid Carcinoma (MTC) <ul><li>Sporadic MTC </li></ul><ul><ul><li>Middle-aged adults </li></ul></ul><ul><ul><li>Female:male = 1.3:1 </li></ul></ul><ul><ul><li>Unilateral involvement of gland </li></ul></ul><ul><ul><li>+/- cervical lymph node metastases </li></ul></ul><ul><ul><li>Indolent course with 60-70% 5-yr survival after thyroidectomy </li></ul></ul>
  • 36. Multiple Endocrine Neoplasia Types IIA & IIB <ul><li>Germ-line mutation in Ret protooncogene on chromosome 10q11.2 </li></ul><ul><li>MEN IIA: MTC, phaeochromocytoma, parathyroid adenoma or hyperplasia </li></ul><ul><li>MEN IIB: MTC, phaeochromocytoma, mucosal ganglioneuromas, Marfanoid habitus, other skeletal abnormalities </li></ul>
  • 37. Medullary Thyroid Carcinoma (MTC) <ul><li>Associated with MEN IIA </li></ul><ul><ul><li>Younger patients in twenties </li></ul></ul><ul><ul><li>Multicentric and bilateral </li></ul></ul><ul><ul><li>Slow growing </li></ul></ul><ul><li>Associated with MEN IIB </li></ul><ul><ul><li>Even younger patients in teens </li></ul></ul><ul><ul><li>Aggressive with early metastasis </li></ul></ul><ul><ul><li>Poor prognosis </li></ul></ul>
  • 38. Medullary Thyroid Carcinoma (MTC) <ul><li>Histology same for sporadic & familial </li></ul><ul><li>Solid, lobular or insular growth patterns </li></ul><ul><li>Tumour cells round, polygonal or spindle-shaped </li></ul><ul><li>Amyloid deposits in many cases </li></ul>
  • 39. Medullary Thyroid Carcinoma (MTC) <ul><li>Amyloid deposits stain orange-red with Congo Red stain </li></ul>
  • 40. Prognosis of Thyroid Carcinomas <ul><li>Papillary Best prognosis </li></ul><ul><li>Follicular </li></ul><ul><li>Medullary </li></ul><ul><li>Anaplastic Worst prognosis </li></ul>
  • 41. Secondary Tumours <ul><li>Direct extensions from: larynx, pharynx, oesophagus etc. </li></ul><ul><li>Metastasis from: renal cell carcinoma, large intestinal carcinoma, malignant melanoma, lung carcinoma, breast carcinoma etc. </li></ul>
  • 42. Solitary thyroid nodule <ul><li>Papillary carcinoma </li></ul><ul><li>Follicular carcinoma </li></ul><ul><li>Medullary carcinoma </li></ul><ul><li>Follicular adenoma </li></ul><ul><li>Hyperplastic (dominant) nodule </li></ul><ul><li>Metastatic neoplasms </li></ul><ul><li>FINE NEEDLE ASPIRATION CYTOLOGY </li></ul>
  • 43. Congenital Thyroid Diseases <ul><li>Agenesis /Aplasia </li></ul><ul><li>Hypoplasia </li></ul><ul><li>Accessory or aberrant thyroid glands </li></ul><ul><li>Thyroglossal duct cyst </li></ul>
  • 44. Thyroglossal Duct Cyst <ul><li>Children </li></ul><ul><li>Failure of regression </li></ul><ul><li>Neck, medial </li></ul><ul><li>Squamous or columnar lining </li></ul><ul><li>Complications: inflammation, sinus tracts </li></ul>

×